CLINICAL_TRIALS
trial_result
· 2017-05-22
Clinical Trial Update: Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon [Phase 2]
Summary
Phase 2 trial reports on the efficacy and tolerability of Ginkgo Biloba Extract for Raynaud's phenomenon; results have been posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VSM Geneesmiddelen b.v. | Conditions: Raynaud Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-05-22